Artikel ; Online: Dihydromyricetin reverses capecitabine-induced peripheral myelin dysfunction through modulation of oxidative stress.
Clinical and experimental pharmacology & physiology
2024 Band 51, Heft 3, Seite(n) e13833
Abstract: Previous clinical reports have shown that capecitabine, an oral prodrug of 5-fluorouracil (5-Fu), can induce peripheral neuropathy, resulting in numbness, paresthesia and hypoesthesia. However, the mechanism through which capecitabine causes peripheral ... ...
Abstract | Previous clinical reports have shown that capecitabine, an oral prodrug of 5-fluorouracil (5-Fu), can induce peripheral neuropathy, resulting in numbness, paresthesia and hypoesthesia. However, the mechanism through which capecitabine causes peripheral nerve injury remains unclear. Here, we demonstrate that systemic administration of capecitabine leads to myelin abnormalities in the peripheral nerves of mice, which are possibly attributed to the death of Schwann cells, the myelinating cells in the peripheral nervous system. Furthermore, our results show that 5-Fu induces significant oxidative stress in Schwann cells by inhibiting the expression of the anti-oxidative protein DJ-1, leading to a decrease in Schwann cell markers. We found that the anti-oxidant dihydromyricetin (DMY) reverses 5-Fu-induced Schwann cell death and oxidative stress and alleviates capecitabine-induced myelin abnormalities. Taken together, our data indicate that capecitabine induces peripheral myelin dysfunction by regulating DJ-1-mediated oxidative stress in Schwann cells and reveal DMY as a potential therapeutic strategy for capecitabine-induced peripheral neuropathy. |
---|---|
Mesh-Begriff(e) | Mice ; Animals ; Myelin Sheath/metabolism ; Capecitabine/metabolism ; Oxidative Stress ; Peripheral Nervous System Diseases/metabolism ; Fluorouracil/toxicity ; Flavonols |
Chemische Substanzen | Capecitabine (6804DJ8Z9U) ; dihydromyricetin (KD8QND6427) ; Fluorouracil (U3P01618RT) ; Flavonols |
Sprache | Englisch |
Erscheinungsdatum | 2024-01-30 |
Erscheinungsland | Australia |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 189277-0 |
ISSN | 1440-1681 ; 0305-1870 ; 0143-9294 |
ISSN (online) | 1440-1681 |
ISSN | 0305-1870 ; 0143-9294 |
DOI | 10.1111/1440-1681.13833 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 990: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.